Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.

Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.

By driving life forward and leading the science that results in breakthrough therapies, Boehringer Ingelheim stays true to its purpose of improving the health of communities today, and for future ...

Our focus is to spread awareness so patients can have more hope and higher chances for a better quality of life," said Dr. Greta Cortez, head of Medicine for Boehringer Ingelheim (Philippines) Inc.

She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well ... But also importantly, the quality of life. Because as we hopefully as an industry and through ...

BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim ... truly look forward to our collaboration with the WHO Foundation and its partners as we want to increase access to life-saving ...